McMaster University

McMaster University

MacBiophotonics

Cell Analysis Platforms

Human Immune Analysis Facility

The Human Immune Analysis Facility runs assays of T cell, B cell, NK cell phenotype and function by flow cytometry, analysis of tumor-specific T cells using ELISPOT and ICS with defined peptides and primary tumor samples and analysis of virus-specific T cells using defined epitopes from West Nile virus, Epstein-Barr virus, cytomegalovirus, influenza virus and vaccinia virus. The facility can also assist with the development of methods using primary tumor samples or monitor responses to other viruses.

Contact Jonathan Bramson for more details.

Flow Cytometry Facility

The McMaster Flow Cytometry Facility provides access to a wide spectrum of investigators at McMaster University, as well as outside users. It is operated in a manner that maximizes user access at a reasonable fee, and provides available expertise to aid the users in experimental design and protocol development. The facility is located in room 2N49, at the Health Sciences Center, within the clinical laboratory. There are three instruments available to the research users. Within the Health Science Center there are two instruments: A three-laser (488 nm, 633 nm, 350-nm UV), 8-colour capable digital sorter, FACSVantageSE instrument and 2) a three laser (488 nm, 633nm) 15-colour capable LSR-II instrument. The third instrument is a 8 colour, 2 laser (488nm, 633nm,405nm) FACS Canto and is located on the 5th floor of the Michael G. DeGroote Center for Learning and Discovery.

Contact the Flow Cytometry Facility for more details.

Biophotonics

MacBiophotonics, located in the Health Sciences Centre 4H14, is an international imaging facility providing access to the latest and best in microscopy, fluorimetry and high content screening. The facility is equipped for four-dimensional multicolour investigation of cells.

Contact MacBiophotonics for more details.

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0